<DOC>
	<DOC>NCT00130832</DOC>
	<brief_summary>The study is being conducted to demonstrate that vaccine to prevent gastroenteritis due to rotavirus may be administered concomitantly with oral polio vaccine (OPV) without impairing the safety or immunogenicity of either vaccine.</brief_summary>
	<brief_title>Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants in good health Previous administration of any oral poliovirus vaccine (OPV) and rotavirus vaccine Receipt of inactivated poliovirus vaccine (IPV) prior to the first dose of either study vaccine, or at any time during the course of the study Any condition resulting in depressed immunity Any allergy to any vaccine component as stated in the package circulars Allergies to polymyxin B, neomycin or any other antibiotics Receipt of intramuscular, oral, or intravenous corticosteroid treatment History of congenital abdominal disorders, intussusception, or abdominal surgery; clinical evidence of active gastrointestinal illness History of known prior rotavirus gastroenteritis, chronic diarrhea, or failure to thrive Prior receipt of a blood transfusion or blood products, including immunoglobulin Fever, with a rectal temperature of ≥38.1°C (≥ 100.5°F) at the time of immunization Infants residing in a household with an immunocompromised person</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>